ASK DRS. OZ & ROIZEN: Reclassifying the drug Vicodin

King Features SyndicateDecember 21, 2013 

Q: I have chronic back pain, and I’ve been taking Vicodin for about a year. Why are the rules changing about how it is prescribed and how often I have to see the doctor?

HENRY G., Evanston, Ill.

A: Let us explain. Vicodin, a combination of the powerful opioid pain reliever hydrocodone bitartrate and acetaminophen, is being reclassified as “possibly” highly addictive and prone to abuse, and will now be considered a schedule II drug. The current rash of abuse of prescription drugs has made it important to establish more control over how Vicodin is dispensed.

Drug-related overdoses are now the leading cause of accidental death for Americans ages 25 to 64 (60 percent of drug overdoses in 2010 were from prescription drugs). In 2010, Vicodin was the most prescribed medication in the U.S.; 131 million prescriptions were filled.

So, instead of allowing your doc to call the pharmacy to renew your prescription every six months, these changes mean you’ll have to see your doc in person for a new written prescription, and you’ll hand-deliver it to the pharmacy every three months. For people with legitimate health issues — like you, Henry — this should make little difference. You’ll continue to get the medication you need to control pain (true, with a little more effort). But seeing your doc every three months when you are taking a potentially addictive drug and have a chronic condition is better health care anyway.

Mehmet Oz, M.D., is host of “The Dr. Oz Show,” and Mike Roizen, M.D., is chief medical officer at the Cleveland Clinic Wellness Institute. To live your healthiest, visit sharecare.com. Distributed by King Features Syndicate, Inc.

Idaho Statesman is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service